Stryker Corporation

Healthcare · Medical Devices

272.40$ +1.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Stryker Corporation (SYK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 25,116 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement SYK
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	910	980	1,103	2,104	2,289	2,602	3,012	3,625	4,262	4,872	5,406	6,001	6,718	6,723	7,320	8,307	8,657	9,021	9,675	9,946	11,325	12,444	13,601	14,884	14,351	17,108	18,449	20,498	22,595	25,116
Cost of Revenue	358	365	435	724	741	964	1,111	1,312	1,558	1,767	1,892	1,907	2,171	2,219	2,344	2,790	2,881	3,078	3,452	3,559	4,079	4,541	5,001	5,502	5,598	6,399	7,409	8,004	8,615	9,051
Gross Profit	552	616	669	1,380	1,549	1,639	1,900	2,313	2,704	3,104	3,513	4,094	4,547	4,504	4,976	5,517	5,776	5,943	6,223	6,387	7,246	7,903	8,600	9,382	8,753	10,709	11,040	12,494	13,980	16,065
Research & Development	57	57	61	105	122	142	141	180	211	285	325	375	368	336	394	462	471	536	614	625	715	787	862	971	905	1,133	1,230	1,293	1,414	1,582
Selling, General & Administrative	327	342	381	808	886	985	1,165	1,416	1,652	1,814	2,062	2,392	2,625	2,506	2,707	3,150	3,466	4,066	3,575	3,610	4,137	4,552	5,099	5,356	5,361	5,752	6,035	7,129	7,685	8,221
Total Operating Expenses	418	432	480	1,015	1,117	1,166	1,336	1,642	1,863	2,138	2,386	2,767	2,993	2,780	3,126	3,546	3,859	3,844	3,994	4,135	4,669	5,136	5,496	5,994	5,725	6,946	7,306	8,213	8,919	11,176
Operating Income	134	184	189	-118	358	472	548	680	841	966	1,127	1,327	1,554	1,724	1,851	1,971	1,917	2,099	2,229	2,252	2,577	2,767	3,104	3,388	3,028	3,763	3,734	4,281	5,061	4,889
Interest Expense	0.0	0.0	0.0	123	97	68	40	23	6.8	7.7	9.5	22	31	15	78	94	67	95	113	108	228	247	264	287	315	337	337	356	396	607
Pre-Tax Income	166	195	60	30	335	406	507	653	717	1,003	1,104	1,370	1,580	1,624	1,730	1,686	1,705	1,212	1,160	1,735	1,921	2,063	2,356	2,562	1,954	2,281	2,683	3,673	3,492	4,514
Income Tax Expense	62	70	20	10	114	134	161	199	251	311	326	383	432	517	456	341	407	206	645	296	274	1,043	-1,197	479	355	287	325	508	499	1,268
Net Income	105	125	40	19	221	267	346	454	466	675	778	1,017	1,148	1,107	1,273	1,345	1,298	1,006	515	1,439	1,647	1,020	3,553	2,083	1,599	1,994	2,358	3,165	2,993	3,246
EBITDA	169	234	242	528	599	645	751	901	975	1,252	1,445	1,759	1,998	2,024	2,217	2,261	2,049	1,614	1,651	2,240	2,695	2,952	3,343	3,627	3,081	3,608	4,018	5,057	4,938	6,314

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings